Alvogen

📍 Pine Brook, United States🗓 Founded 2009👥 571 employees💰 Last funded Sep 2015
Pharmaceutical Manufacturing🌐 alvogen.com
Website LinkedIn
Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the-counter brands (OTC) and biosimilar products for patients around the world. We are passionate about making people’s lives better by making high quality medicines more accessible around the world. The company has commercial operations in 35 countries with 2,800 employees and operates four manufacturing and development hubs in the U.S., Romania, Korea and Taiwan. North America is Alvogen’s single largest market and other key markets include: South Korea, Russia, Taiwan, Romania, Hungary, Ukraine, Japan and China.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2009
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Denmark
1
Frequently asked questions
Who invested in Alvogen?
Alvogen has 1 investors on record on gritt.io and 1 late-stage investors.
When did Alvogen last raise funding?
The most recent investment in Alvogen recorded on gritt.io was in September 2015.
When was Alvogen founded?
Alvogen was founded in 2009.
What industry is Alvogen in?
Alvogen operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Alvogen based?
Alvogen is headquartered in Pine Brook, United States.